Cargando…

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification

The quest for neuroprotective drugs to slow the progression of neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD), has been largely unrewarding. Preclinical evidence suggests that repurposing quetiapine, lithi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lauterbach, Edward C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204212/ https://www.ncbi.nlm.nih.gov/pubmed/28123400 http://dx.doi.org/10.4103/1673-5374.194708

Ejemplares similares

Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
por: Lauterbach, Edward C.
Publicado: (2013)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
por: Lauterbach, Edward C., et al.
Publicado: (2012)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

Functional compensation of motor function in pre-symptomatic Huntington's disease
por: Klöppel, Stefan, et al.
Publicado: (2009)

Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington’s Disease Status Based on Omics Data
por: Christodoulou, Christiana C., et al.
Publicado: (2020)

Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy
por: Sampaio, Tuane Bazanella, et al.
Publicado: (2017)

Promises and pitfalls of immune-based strategies for Huntington's disease
por: Colpo, Gabriela Delevati, et al.
Publicado: (2017)

New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases
por: Hölscher, Christian
Publicado: (2014)

Bioinformatic gene analysis for potential therapeutic targets of Huntington’s disease in pre-symptomatic and symptomatic stage
por: Xiang, Chunchen, et al.
Publicado: (2020)

Prevalence of Non-psychiatric Comorbidities in Pre-symptomatic and Symptomatic Huntington's Disease Gene Carriers in Poland
por: Zielonka, Daniel, et al.
Publicado: (2020)

Identification of psychoeducation needs and an intervention response for pre-symptomatic Huntington’s disease
por: Gluyas, Cathy, et al.
Publicado: (2022)

Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases
por: Freyssin, Aline, et al.
Publicado: (2018)

A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington's disease
por: Hinzen, Wolfram, et al.
Publicado: (2018)

Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis
por: Liss, J. L., et al.
Publicado: (2021)

Revisiting the neuropsychiatry of Huntington's disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016)

Direction of Information Flow in Alzheimer's Disease and MCI Patients
por: Vecchio, Fabrizio, et al.
Publicado: (2011)

Mitochondrial and redox modifications in early stages of Huntington's disease
por: Lopes, Carla, et al.
Publicado: (2022)

Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test
por: Pozueta, Ana, et al.
Publicado: (2011)

Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021)

Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson’s disease
por: Yoo, Hajung, et al.
Publicado: (2022)

Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells
por: Deng, Peter, et al.
Publicado: (2016)

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2019)

Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease
por: Cohen, Shani, et al.
Publicado: (2018)

Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time
por: Hendrix, Suzanne B
Publicado: (2012)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
por: Chatzikostopoulos, Athanasios, et al.
Publicado: (2022)

The adjustment of γ-aminobutyric acid(A) tonic subunits in Huntington's disease: from transcription to translation to synaptic levels into the neostriatum
por: Rosas-Arellano, Abraham, et al.
Publicado: (2018)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
por: Munawara, Usma, et al.
Publicado: (2021)

FOOD AND SUPPLEMENT COMBINATIONS TO PREVENT OR POSTPONE AGING, MCI, AND ALZHEIMER’S DISEASE
por: Pruchnicki, Alec, et al.
Publicado: (2022)

The role of ethnicity, biological sex, and psychotropic agents in early and late onset Alzheimer’s disease
por: Miller, Alyssa, et al.
Publicado: (2022)

Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease
por: de Paula Nascimento-Castro, Cristine, et al.
Publicado: (2018)

Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
por: Jones, Ann J., et al.
Publicado: (2017)

Frontiers in the pathogenesis of Alzheimer’s disease
por: Sambamurti, Kumar, et al.
Publicado: (2009)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Macrophage function in obesity-induced inflammation and insulin resistance
por: Lauterbach, Mario A. R., et al.
Publicado: (2017)

Morphological and Microstructural Changes of the Hippocampus in Early MCI: A Study Utilizing the Alzheimer's Disease Neuroimaging Initiative Database
por: Lee, Peter, et al.
Publicado: (2017)

Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging()
por: Nir, Talia M., et al.
Publicado: (2013)

EEG oscillations during word processing predict MCI conversion to Alzheimer's disease
por: Mazaheri, Ali, et al.
Publicado: (2017)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h4e534er4tf2jrlisuq9lum5rc